Understanding how social factors affect Alzheimer's diagnosis in diverse communities
Official title: Social determinants of racial and ethnic disparities in ADRD diagnostic pathways
Funded at University of California, San Francisco · NIH-10746016 · Data updated 2026-11-12
This study looks at how things like income and healthcare access affect the diagnosis and treatment of Alzheimer's and related dementias in older adults from different racial and ethnic backgrounds, aiming to find ways to improve care for everyone.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | December 1, 2022 |
| Project end | November 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $161,500 |
| NIH project number | 5R21AG080410-02 |
| Project ID | NIH-10746016 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include older adults from racially and ethnically diverse backgrounds who are experiencing symptoms of Alzheimer's disease or related dementias.
✕Less likely to help
Patients who are not from diverse racial or ethnic backgrounds or who do not have Alzheimer's disease or related dementias may not benefit from this research.
What this research studies
This research investigates how social determinants of health, such as socioeconomic status and access to healthcare, influence the diagnosis and care of Alzheimer's disease and related dementias (ADRD) among racially and ethnically diverse older adults. By analyzing data from Medicare beneficiaries, the study aims to identify key social factors that impact the timeliness and accuracy of ADRD diagnoses and access to necessary care. The research will also explore how these social determinants mediate disparities in healthcare outcomes for different racial and ethnic groups, providing insights that could improve diagnostic pathways and care access for affected individuals.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic processes and healthcare access for diverse populations affected by Alzheimer's disease.
How similar studies have gone: Previous research has shown that addressing social determinants can significantly impact health outcomes, suggesting that this approach may yield valuable insights.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Tsoy, Elena — University of California, San Francisco
- Study coordinator: Tsoy, Elena
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.